يعرض 1 - 10 نتائج من 11 نتيجة بحث عن '"Endocrine System Diseases::Diabetes Mellitus::Diabetes Complications::Diabetic Angiopathies::Diabetic Retinopathy [DISEASES]"', وقت الاستعلام: 1.64s تنقيح النتائج
  1. 1

    المساهمون: Institut Català de la Salut, [Alcubierre N] Avantmedic Center, Lleida, Spain. [Granado-Casas M] Department of Nursing and Physiotherapy, Health Sciences Faculty, University of Lleida, Lleida, Spain. Institute of Biomedical Research in Lleida (IRBLleida), Lleida, Spain. Center for Biomedical Research on Diabetes and Associated Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III, Barcelona, Spain. DAP-Cat Group, Unitat de Suport a la Recerca Barcelona, Institut Universitari d’Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), Barcelona, Spain. [Bogdanov P, Hernández C, Ramos H, Simó R] Center for Biomedical Research on Diabetes and Associated Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III, Barcelona, Spain. Grup de Recerca de Diabetis i Metabolisme, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Castelblanco E] DAP-Cat Group, Unitat de Suport a la Recerca Barcelona, Institut Universitari d’Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), Barcelona, Spain. Endocrinology, Metabolism and Lipid Research Division, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Nutrients; Volume 15; Issue 5; Pages: 1169
    Scientia

    وصف الملف: application/pdf

  2. 2

    المساهمون: Institut Català de la Salut, [Ramos H, Hernández C, Simó R, Simó-Servat O] Grup de Recerca en Diabetis i Metabolisme, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ICSIII), Madrid, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

  3. 3

    المساهمون: Institut Català de la Salut, [Fedotkina O, Özgümüs T] Department of Clinical Science, Center for Diabetes Research, University of Bergen, Bergen, Norway. [Jain R, Prasad RB] Department of Clinical Sciences, Lund University Diabetes Center, Skane University Hospital, Malmö, Sweden. [Luk A] Prince of Wales Hospital, Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China. [García-Ramírez M, Simo R] Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. CIBERDEM, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia
    Frontiers in Neuroscience

    وصف الملف: application/pdf

  4. 4

    المساهمون: Institut Català de la Salut, [Ramos H, Bogdanov P, Hernández C, Simó R] Unitat de Recerca en Diabetis i Metabolisme, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ICSIII), Madrid, Spain. [Sabater D, Huerta J] Unitat de Recerca en Diabetis i Metabolisme, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Valeri M] Unitat d'Alta Tecnologia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Biomedicines
    Biomedicines; Volume 9; Issue 12; Pages: 1772
    Scientia
    Biomedicines, Vol 9, Iss 1772, p 1772 (2021)

    مصطلحات موضوعية: enfermedades del sistema endocrino::diabetes mellitus::complicaciones de la diabetes::angiopatías diabéticas::retinopatía diabética [ENFERMEDADES], Synapsin I, Endocrine System Diseases::Diabetes Mellitus::Diabetes Complications::Diabetic Angiopathies::Diabetic Retinopathy [DISEASES], QH301-705.5, Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Enzyme Inhibitors::Protease Inhibitors::Dipeptidyl-Peptidase IV Inhibitors [CHEMICALS AND DRUGS], diabetic retinopathy, retinal neurodegeneration, dipeptidyl peptidase 4 inhibitors, sitagliptin, presynaptic proteins, db/db mouse model, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Medicine (miscellaneous), Pharmacology, Other subheadings::Other subheadings::/drug therapy [Other subheadings], Peptidases - Inhibidors, General Biochemistry, Genetics and Molecular Biology, Article, Downregulation and upregulation, acciones y usos químicos::acciones farmacológicas::mecanismos moleculares de acción farmacológica::inhibidores enzimáticos::inhibidores de proteasas::inhibidores de la dipeptidil-peptidasa IV [COMPUESTOS QUÍMICOS Y DROGAS], Medicine, Other subheadings::/therapeutic use [Other subheadings], Biology (General), biology, VAMP2, Otros calificadores::/uso terapéutico [Otros calificadores], STX1A, business.industry, SNAP25, Retinopatia diabètica - Tractament, Membrane protein, Sitagliptin, Synaptophysin, biology.protein, business, medicine.drug

    وصف الملف: application/pdf

  5. 5

    المساهمون: [Hernández C, Bogdanov P, Sampedro J, Solà-Adell C, García-Ramírez M, Simó R] Grup de Diabetis i Metabolisme, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain. [Gómez-Guerrero C] Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain. Renal, Vascular and Diabetes Research Lab, Instituto de Investigacion Sanitaria-Fundación Jimenez Diaz (IIS-FJD), Madrid, Spain. Autonoma University of Madrid (UAM), Madrid, Spain. [Espejo, C] Recerca en Neuroimmunologia clínica, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain., Hospital Universitari Vall d'Hebron

    المصدر: Scientia

  6. 6

    المساهمون: [Lopes de Faria JM, Duarte DA, Dátilo MN, Pasqualetto FC] Renal Pathophysiology Laboratory, Investigation on Diabetes Complications, Faculty of Medical Sciences, State University of Campinas (UNICAMP), Campinas, Brazil. [Simó R, García-Ramirez M] Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain, Hospital Universitari Vall d'Hebron

    المصدر: Scientia

  7. 7

    المساهمون: Institut Català de la Salut, [Carbonell M] Department of Ophthalmology, University Hospital Germans Trias i Pujol, Badalona, Spain. Department of Surgery, Barcelona Autonomous University (UAB), Barcelona, Spain. [Alonso N] Department of Endocrinology and Nutrition, University Hospital and Health Science Research Institute Germans Trias i Pujol, Badalona, Spain. Centre for Biomedical Research on Diabetes and Associated Metabolic Diseases (CIBERDEM), Barcelona, Spain. Department of Medicine, Barcelona Autonomous University (UAB), Barcelona, Spain. [Castelblanco E] Centre for Biomedical Research on Diabetes and Associated Metabolic Diseases (CIBERDEM), Barcelona, Spain. Department of Endocrinology & Nutrition, Hospital de la Santa Creu i Sant Pau & Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau), Barcelona, Spain. DAP-Cat Group, Unitat de Suport a la Recerca Barcelona, Fundació Institut Universitari per a la Recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain. [Real J] Centre for Biomedical Research on Diabetes and Associated Metabolic Diseases (CIBERDEM), Barcelona, Spain. DAP-Cat Group, Unitat de Suport a la Recerca Barcelona, Fundació Institut Universitari per a la Recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain. [Ramírez-Morros A] Department of Endocrinology and Nutrition, University Hospital and Health Science Research Institute Germans Trias i Pujol, Badalona, Spain. [Simó R, Hernández C] ] Centre for Biomedical Research on Diabetes and Associated Metabolic Diseases (CIBERDEM), Barcelona, Spain. Servei d’Endocrinologia i Nutrició, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Grup de recerca en Diabetis i Metabolisme, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain, Hospital Universitari Vall d'Hebron

    المصدر: Scientia

  8. 8

    المساهمون: Institut Català de la Salut, [Planas A, Simó-Servat O, Hernández C, Ortiz-Zúñiga Á, Simó R] Unitat de Recerca en Diabetis i Metabolisme, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Spanish Institute of Health (ISCIII), 28029 Madrid, Spain. [Marsal JR, Ferreira-González I] Servei de Cardiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. CIBER en Epidemiología y Salud Pública (CIBERESP), Spanish Institute of Health (ISCIII), 28029 Madrid, Spain. [Hernández C] Grup de Recerca en Imatge Molecular Mèdica, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Servei de Medicina Nuclear, Vall d’Hebron Hospital Universitari, Barcelona, Spain. CIBBIM-Nanomedicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. CIBERBBN, Spanish Institute of Health (ISCIII), 28029 Madrid, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia
    Journal of Personalized Medicine
    Journal of Personalized Medicine, Vol 11, Iss 1344, p 1344 (2021)
    Journal of Personalized Medicine; Volume 11; Issue 12; Pages: 1344

    وصف الملف: application/pdf

  9. 9

    المساهمون: [Hernández C, Bogdanov P, Sampedro J, Solà-Adell C, García-Ramírez M, Simó R] Grup de Diabetis i Metabolisme, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain. [Gómez-Guerrero C] Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain. Renal, Vascular and Diabetes Research Lab, Instituto de Investigacion Sanitaria-Fundación Jimenez Diaz (IIS-FJD), Madrid, Spain. Autonoma University of Madrid (UAM), Madrid, Spain. [Espejo, C] Recerca en Neuroimmunologia clínica, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain., Vall d'Hebron Barcelona Hospital Campus, UAM. Departamento de Medicina

    المصدر: Scientia
    Dipòsit Digital de Documents de la UAB
    Universitat Autònoma de Barcelona
    International Journal of Molecular Sciences, Vol 20, Iss 15, p 3615 (2019)
    International Journal of Molecular Sciences
    Volume 20
    Issue 15
    Biblos-e Archivo. Repositorio Institucional de la UAM
    instname

    مصطلحات موضوعية: 0301 basic medicine, Amino Acids, Peptides, and Proteins::Amino Acids, Peptides, and Proteins::Proteins::Amino Acids, Peptides, and Proteins::Proteins::Intracellular Signaling Peptides and Proteins::Adaptor Proteins, Signal Transducing::Suppressor of Cytokine Signaling Proteins [CHEMICALS AND DRUGS], Endocrine System Diseases::Diabetes Mellitus::Diabetes Complications::Diabetic Angiopathies::Diabetic Retinopathy [DISEASES], aminoácidos, péptidos y proteínas::péptidos::péptidos y proteínas de señalización intracelular::proteínas adaptadoras transductoras de señales::proteínas supresoras de la señalización de citocinas [COMPUESTOS QUÍMICOS Y DROGAS], medicine.medical_treatment, Pharmacology, neuroinflammation, Pathogenesis, lcsh:Chemistry, Mice, chemistry.chemical_compound, 0302 clinical medicine, Medicine, Retina - Vasos sanguinis, lcsh:QH301-705.5, Spectroscopy, General Medicine, Diabetic retinopathy, db/db mouse, Quimiocines, Computer Science Applications, diabetic retinopathy, Cytokine, enfermedades del sistema endocrino::diabetes mellitus::complicaciones de la diabetes::angiopatías diabéticas::retinopatía diabética [ENFERMEDADES], Medicina, Cardiovascular System::Blood-Retinal Barrier [ANATOMY], Article, Retina, Catalysis, Diabetes Mellitus, Experimental, Proinflammatory cytokine, Inorganic Chemistry, 03 medical and health sciences, Suppressor of Cytokine Signaling 1 Protein, Electroretinography, Animals, Humans, Physical and Theoretical Chemistry, Molecular Biology, Neuroinflammation, Inflammation, business.industry, Suppressor of cytokine signaling 1, Organic Chemistry, Retinal, suppressors of cytokine signaling, medicine.disease, sistema cardiovascular::barrera hematorretinal [ANATOMÍA], Disease Models, Animal, Db/db Mouse, 030104 developmental biology, chemistry, lcsh:Biology (General), lcsh:QD1-999, Retinopatia diabètica, 030221 ophthalmology & optometry, microvascular impairment, Ophthalmic Solutions, Peptides, business

    وصف الملف: application/pdf

  10. 10

    المساهمون: [Lopes de Faria JM, Duarte DA, Dátilo MN, Pasqualetto FC] Renal Pathophysiology Laboratory, Investigation on Diabetes Complications, Faculty of Medical Sciences, State University of Campinas (UNICAMP), Campinas, Brazil. [Simó R, García-Ramirez M] Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Dipòsit Digital de Documents de la UAB
    Universitat Autònoma de Barcelona
    Scientia

    مصطلحات موضوعية: Blood Glucose, Male, Vascular Endothelial Growth Factor A, 0301 basic medicine, Endocrine System Diseases::Diabetes Mellitus::Diabetes Complications::Diabetic Angiopathies::Diabetic Retinopathy [DISEASES], Retinal pigmented epithelial, Retinal Pigment Epithelium, Occludin, Catechin, Mice, chemistry.chemical_compound, 0302 clinical medicine, Diabetic retinopathy, Amino Acids, Peptides, and Proteins::Proteins::Membrane Proteins::Receptors, Cell Surface::Receptors, G-Protein-Coupled::Receptors, Opioid::Receptors, Opioid, delta [CHEMICALS AND DRUGS], Receptors, Opioid, delta, Claudin-1, Electric Impedance, RNA, Small Interfering, Retina - Vasos sanguinis, Fluorescent Antibody Technique, Indirect, aminoácidos, péptidos y proteínas::proteínas::proteínas de membranas::receptores de superficie celular::receptores acoplados a proteínas G::receptores opioides::receptores opiodes delta [COMPUESTOS QUÍMICOS Y DROGAS], Tight junction, Diabetes, Middle Aged, Immunohistochemistry, medicine.anatomical_structure, Female, Retinopathy, enfermedades del sistema endocrino::diabetes mellitus::complicaciones de la diabetes::angiopatías diabéticas::retinopatía diabética [ENFERMEDADES], medicine.medical_specialty, Cardiovascular System::Blood-Retinal Barrier [ANATOMY], Blotting, Western, Blood–retinal barrier, Real-Time Polymerase Chain Reaction, Diabetes Mellitus, Experimental, Tight Junctions, 03 medical and health sciences, Neurotransmissors - Receptors, Downregulation and upregulation, Internal medicine, Glial Fibrillary Acidic Protein, medicine, Animals, Humans, Nerve Growth Factors, Eye Proteins, Serpins, Aged, Retina, D opioid receptor, Diabetic Retinopathy, Retinal, medicine.disease, sistema cardiovascular::barrera hematorretinal [ANATOMÍA], eye diseases, Mice, Inbred C57BL, 030104 developmental biology, Endocrinology, chemistry, Retinopatia diabètica, Zonula Occludens-1 Protein, sense organs, 030217 neurology & neurosurgery

    وصف الملف: application/pdf